Physiologically clotted fibrin - Preparation and characterization for tissue engineering and drug delivery applications

Biologicals

Volumn 42, Issue 5, 2014, Pages 277-284

  Vedakumari, Weslen S ^a   Sastry, Thotapalli P ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

Alkaline phosphatase; Bone tissue engineering; Drug delivery; Fluorescence microscopy; Gallic acid; Physiologically clotted fibrin

Indexed keywords

ALKALINE PHOSPHATASE; BLOOD CLOTTING FACTOR; CALCIUM; CONVENTIONALLY PREPARED FIBRIN; FIBRIN; GALLIC ACID; PHYSIOLOGICALLY CLOTTED FIBRIN; UNCLASSIFIED DRUG; APATITE; BIOMATERIAL;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOCOMPATIBILITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRUG RESPONSE; ENZYME ASSAY; FLUORESCENCE MICROSCOPY; HEMOLYSIS; HUMAN; HUMAN CELL; MECHANICAL STRENGTH; NONHUMAN; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; TISSUE ENGINEERING; 3T3 CELL LINE; ANIMAL; BIODEGRADABLE IMPLANT; BONE DEVELOPMENT; BOVINE; CELL LINE; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; ISOLATION AND PURIFICATION; MATERIALS TESTING; METABOLISM; MOUSE; OSTEOBLAST; TENSILE STRENGTH;

ABSORBABLE IMPLANTS; ALKALINE PHOSPHATASE; ANIMALS; APATITES; BIOCOMPATIBLE MATERIALS; CALCIUM; CATTLE; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; DRUG DELIVERY SYSTEMS; FIBRIN; HEMOLYSIS; HUMANS; MATERIALS TESTING; MICE; NIH 3T3 CELLS; OSTEOBLASTS; OSTEOGENESIS; TENSILE STRENGTH; TISSUE ENGINEERING;

EID: 84908206429     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2014.06.004     Document Type: Article

References (35)

1. Wang G.J., Hungerford D.S., Savory C.G., Rosenberg A.G., Mont M.A., Burks S.G., et al. Use of fibrin sealant to reduce bloody drainage and haemoglobin loss after total knee arthroplasty: a brief note on a randomized prospective trial. JBone Jt Surg Am 2001, 83:1503-1505.
2. Zangi L., Rivkin R., Kassis I., Levdansky L., Marx G., Gorodetsky R. High-yield isolation, expansion, and differentiation of rat bone marrow-derived mesenchymal stem cells with fibrin microbeads. Tissue Eng 2006, 12:2343-2354.
3. Schmoekel H.G., Weber F.E., Schense J.C., Grätz K.W., Schawalder P., Hubbell J.A. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell in growth matrices. Biotechnol Bioeng 2005, 89:253-262.
4. Zhou H., Xu H.H. The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds in bone tissue engineering. Biomaterials 2011, 32:7503-7513.
5. Acevedo C.A., Somoza R.A., Weinstein-Oppenheimer C., Brown D.I., Young M.E. Growth factor production from fibrin-encapsulated human kertinocytes. Biotechnol Lett 2010, 32:1011-1017.
6. Catelas I., Dwyer J.F., Helgerson S. Controlled release of bioactive transforming growth factor beta-1 from fibrin gels invitro. Tissue Eng Part C Methods 2008, 14:119-128.
7. Spicer P.P., Mikos A.G. Fibrin glue as a drug delivery system. JControl Release 2010, 148:49-55.
8. Gorodetsky R., Peylan-Ramu N., Reshef A., Gaberman E., Levdansky L., Marx G. Interactions of carboplatin with fibrin(ogen), implication for local slow release chemotherapy. JControl Release 2005, 102:235-245.
9. Janmey P.A., Winer J.P., Weisel J.W. Fibrin gels and their clinical and bioengineering applications. JSoc Interface 2009, 6:1-10.
10. Gurevich O., Vexler A., Marx G., Prigozhina T., Levdansky L., Slavin S., et al. Fibrin microbeads for isolating and growing bone marrow derived progenitor cells capable of forming bone tissue. Tissue Eng 2002, 8:661-672.
11. Silver F.H., Wang M.C., Pins G.C. Preparation and use of fibrin glue in surgery. Biomaterials 1995, 16:891-903.
12. Babu B.R., Sastry T.P., Rose C., Rao N.M. Hydrogels based on gelatin poly (hydroxyethyl methacrylate) and poly (butyl acrylate) graft copolymer impregnated with fibrin. JAppl Polym Sci 1997, 65:555-560.
13. Noorjahan S.E., Sastry T.P. Physiologically clotted fibrin-calcined bone composite-a possible bone graft substitute. JBiomed Mater Res B Appl Biomater 2005, 75:343-350.
14. Vedakumari W.S., Prabu P., Babu S.C., Sastry T.P. Fibrin nanoparticles as possible vehicles for drug deliveryBiochim. Biophys Acta 2013, 1830:4244-4253.
15. Weiss M., Manneberg M., Juranville J.F., Lahm H.W., Fountoulakis W. Effect of the hydrolysis method on the determination of the amino acid composition of proteins. JChromatogr A 1998, 795:263-275.
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. JImmunol Methods 1983, 65:55-63.
17. Fischer D., Li Y., Ahlemeyer B., Krieglstein J., Kissel T. Invitro cytotoxicity testing of polycations: influence of polymer structure on cell viability and hemolysis. Biomaterials 2003, 24:1121-1131.
18. Zobel H.P., Stieneker F., Atmaca-Abdel Aziz S., Gilbert M., Werner D., Noe C.R., et al. Evaluation of aminoalkylmethacrylate nanoparticles as colloidal drug carrier systems. Part II: characterization of antisense oligonucleotides loaded copolymer nanoparticles. Eur J Pharm Biopharm 1999, 48:1-12.
19. Osathanon T., Giachelli C.M., Somerman M.J. Immobilization of alkaline phosphatase on microporous nanofibrous fibrin scaffolds for bone tissue engineering. Biomaterials 2009, 30:4513-4521.
20. Wang J., Yu X. Preparation, characterization and invitro analysis of novel structured nanofibrous scaffolds for bone tissue engineering Acta. Biomater 2010, 6:3004-3012.
21. Bramanti E., Benedetti E., Sagripanti A., Papineschi F., Benedetti E. Determination of secondary structure of normal fibrin from human peripheral blood. Biopolymers 1997, 41:545-553.
22. Tunc S., Maitz M.F., Steiner G., Vázquez L., Pham M.T., Salzer R. In situ conformational analysis of fibrinogen adsorbed on Si surfaces. Colloids Surf B Biointerfaces 2005, 42:219-225.
23. Lin S.Y., Wei Y.S., Hsieh T.F., Li M.J. Pressure dependence of human fibrinogen correlated to the conformational alpha-helix to beta-sheet transition: an Fourier transform infrared study microspectroscopic study. Biopolymers 2004, 75:393-402.
24. Dong A., Kendrick B., Kreilgârd L., Matsuura J., Manning M.C., Carpenter J.F. Spectroscopic study of secondary structure and thermal denaturation of recombinant human factor XIII in aqueous solution. Arch Biochem Biophys 1997, 347:213-220.
25. McCarron B.I., Marder V.J., Kanouse J.J., Francis C.W. Asoluble fibrin standard: comparable dose-response with immunologic and functional assays. Thromb Haemost 1999, 82:145-148.
26. McKee P.A., Mattock P., Hill R.L. Subunit structure of human fibrinogen, soluble fibrin, and cross-linked insoluble fibrin. Proc Natl Acad Sci U S A 1970, 66:738-744.
27. Mangalathillam S., Rejinold N.S., Nair A., Lakshmanan V.K., Nair S.V., Jayakumar R. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route. Nanoscale 2012, 4:239-250.
28. Piattelli A., Scarano A., Corigliano M., Piattelli M. Effects of alkaline phosphatase on bone healing around plasma-sprayed titanium implants: a pilot study in rabbits. Biomaterials 1996, 17:1443-1449.
29. Kocabey S., Ceylan H., Tekinay A.B., Guler M.O. Glycosaminoglycan mimetic peptide nanofibers promote mineralization by osteogenic cells. Acta Biomater 2013, 9:9075-9085.
30. Kim Y.J. Antimelanogenic and antioxidant properties of gallic acid. Biol Pharm Bull 2007, 30:1052-1055.
31. Borde V., Pangrikar P., Tekale S. Gallic acid in ayurvedic herbs and formulations. Rec Res Sci Tech 2011, 3:51-54.
32. Raina K., Rajamanickam S., Deep G., Singh M., Agarwal R., Agarwal C. Chemopreventive effects of oral gallic acid feeding on tumor growth and progession in TRAMP mice. Mol Cancer Ther 2008, 7:1258-1267.
33. Mohammed-Ziegler I., Billes F. Vibrational spectroscopic calculations on pyrogallol and gallic acid. JMol Struct 2002, 618:259-265.
34. Serrano A., Palacios C., Roy G., Cespon C., Villar M.L., Nocito M., et al. Derivatives of gallic acid induce apoptosis in tumoral cell lines and inhibit lymphocyte proliferation. Arch Biochem Biophys 1998, 350:49-54.
35. Inoue M., Sakaguchi N., Isuzugawa K., Tani H., Ogihara Y. Role of reactive oxygen species in gallic acid-induced apoptosis. Biol Pharm Bull 2000, 23:1153-1157.